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The aim of this study was to investigate the characteristic those with a negative autologous serum test and no
evident circulating histamine-releasing factors. Seracytokine pattern of patients with chronic idiopathic urtic-
aria. Using  ow cytometry, we examined the frequency from patients with CIU containing anti-FceRIa antibod-
ies can cause weal formation on intradermal injectionof IL-4, IL-10, IL-13 and IFN-c producing CD4+ and
CD8+ T cells in the peripheral blood mononuclear cells in vivo and histamine release from basophils and mast
cells in vitro (3, 4). For some cases of CIU, the conceptat a single cell level. In patients with chronic idiopathic
urticaria, the frequency of IL-10 producing CD4+ and of an autoimmune aetiology is also supported by its
association with HLA-DR4 and with autoimmune thyr-CD8+ T cells was signi cantly higher than that of control
subjects, while the frequency of IFN-c producing helper oid diseases, and by the observation that treatment with
intravenous immunoglobulin or plasmapheresis mayand cytotoxic T cells was signi cantly lower. The propor-
tion of IL-4 producing CD4+ T cells from patients with produce clinical remission (5–9).
In both mice and humans, functionally distinct helperurticaria was signi cantly lower. The ratio of IL-4 produ-
cing CD8+ T cells and the proportion of IL-13 producing T cell subsets, known as Th1 and Th2 cells, are charac-
terized by the patterns of cytokines they produce; aCD4+ and CD8+ T lymphocytes did not show any
signi cant diVerence between patients and controls. In distinction can also be made between cytotoxic (Tc)
cells (10, 11). This classi cation of the cellular immuneour study, we could observe neither a dominant Th1 nor
a dominant Th2 type cytokine pattern. We found a response is a useful model for explaining both the
diVerent types of protection as well as the pathogenicsigni cant elevation in the intracellular IL-10 level which
may be the cause of the down-regulated Th1 and Tc1 and mechanisms of several immunopathological disorders.
A prevalent Th1 lymphokine pro le is observed inpartly Th2 lymphocyte functions. Key words: chronic
urticaria; cytokines;  ow cytometry; Th1; Th2. organ-speci c autoimmune diseases, whereas Th2 cell
responses tend to predominate in systemic sclerosis and(Accepted April 17, 2002.)
in allergic diseases (12, 13).
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mononuclear cells (PBMC) at a single cell level.
Urticaria is a common skin reaction characterized by MATERIALS AND METHODS
transient, pruritic, slightly erythematous weals is de ned
as chronic if occuring daily, or almost daily, over the
Patients and controlscourse of at least 6 weeks. The diagnosis of chronic
idiopathic urticaria (CIU ) can be made by the exclusion Twenty-two patients (4 men and 18 women, mean age 40
years, range 11–76) with almost daily attacks of urticaria andof urticarial vasculitis, predominant physical urticarias,
a mean continuous disease duration of 16.3 months (rangeknown causative foods or drugs and intercurrent febrile
3–48) were investigated. A primary diagnosis of CIU was
illnesses or infectious disease states (1). made when an aetiologic factor accounting for the majority of
Emerging data are providing new evidence that CIU, lesions could not be elicited from history, physical or labora-
tory evaluations. We excluded patients with lesions lasting forin at least a subset of patients, is an autoimmune disease
more than 24 h and suspicious for urticaria vasculitis, patients(2). Sabroe & Greaves (1) identi ed three groups of
with physical urticarias, with food allergy or those takingpatients with CIU: (i) those with functional circulating
drugs that could exacerbate chronic urticaria. None of the
autoantibodies to FceRIa or to IgE, (ii) those with mast patients had an infectious disease. Fourteen (63.3%) patients
cell-speci c histamine-releasing activity with heat stable gave an immediate weal response to an autologous serum
skin test and two (9%) of these had anti-thyroid antibodies.factors and non-immunoglobulin mediator, and (iii)
© 2002 Taylor & Francis. ISSN 0001-5555 Acta Derm Venereol 82
250 B. Irinyi et al.
Antihistamine treatment was stopped 4 days before skin- Statistical analysis
testing and blood-taking. Control blood samples were also
Data were analysed by two-tailed Student’s t-test forobtained from 22 healthy volunteers (6 men and 16 women,
unpaired samples.mean age 36 years, range 15–60).
RESULTSMeasurement of immunoglobulin levels
Serum IgG, IgA, IgM, IgE, IgG1, IgG2, IgG3 and IgG4 levels Serum immunoglobulin levels
were measured by a BEHRING nephelometer (Dade Behring,
We measured the serum immunoglobulin levels in theLeiderbach, Germany).
blood of patients with CIU by nephelometry. In the
case of IgA, IgM and IgG levels we did not see signi cant
Detection of allergen-speci c IgE deviations when comparing data of the patients and the
control group (data not shown). The level of IgE inFood and inhalant allergens were detected by ‘‘Allergoset-
IgE Food’’ and ‘‘Allergoset-IgE Inhalant’’ kits (INTEX patients with CIU was elevated, but statistically it was
Diagnostika, Basel ). not signi cant (Table I ). Allergen-speci c IgE was not
detected in the sera of our patients, and the rate of
eosinophil granulocytes did not diVer signi cantly com-Detection of lymphocyte subpopulations and activated T cells
pared to the healthy controls (data not shown).
Heparinized venous whole blood was stained with anti-human
monoclonal antibodies (mAb) – anti-CD3-FITC, anti-
CD8-FITC (both from Sigma, St. Louis, MO, USA), anti- Frequency of CD3+ , CD4+ , CD8+ and CD19+ cells
CD4-PE, anti-CD19-PerCP, anti-CD69-PE or anti-HLA-DR-
in PBMCRD1 (all from Coulter-Immunotech, Hialeah, FL, USA) –
for 30min at room temperature in darkened conditions. PBMC from 22 healthy control subjects and 22 patients
Erythrocytes were lysed and stained cells were  xed using the
with CIU were examined for the frequency of CD3+ ,Coulter QPrep protocol. The  uorescence analysis was per-
CD4+ , CD8+ , and CD19+ T cells by  ow cytometry.formed on a Coulter EPICS XL-4  ow cytometer (Coulter
Hialeah, FL, USA) with a 488 nm argon ion laser. Emitted The actual lymphocyte subpopulations were separated
 uorescence was determined by means of 525, 575 and 635 nm on the basis of cell surface markers (CD molecules). In
bandpass  lters. Data of 5000 cells were acquired and analysed the case of CIU patients, the proportion of CD3+ ,
by System II software. Gates were set on lymphocytes accord-
CD4+ , CD8+ and CD19+ T and B lymphocytes diding to forward and side-scatter properties, and results were
not show any signi cant deviation compared with theexpressed as the percentage of surface CD markers in the
lymphocyte gate. control group. We also determined the percentage of
activated T cells within the T lymphocyte population.
While examining T lymphocytes producing surfaceMeasurement of intracytoplasmic cytokines
HLA-DR molecules, a signi cantly increased number
Heparinized whole blood (1ml ) was diluted at a 1 for 2 of HLA-DR + /CD3+ T cells was observed as com-
volume rate in RPMI (Sigma). T cells were stimulated with pared with the control subjects (3.84 ± 2.31% versusphorbole myristate acetate (Sigma, 25 ng/ml) and ionomycin
1.55 ± 0.75%; p< 0.01). In the case of the other activa-(Sigma, 1 mg/ml) for 4 h at 37°C in a humidi ed CO2 incub- tion marker (CD3+ /CD69+ ), we could not observeator. Blockage of cytokine secretion and intracellular accu-
mulation was achieved by treating with Brefeldin A (Sigma, any diVerences compared with the control group
10 mg/ml). The CD4 + and CD8 + cells were stained with (0.92 ± 0.49% versus 0.98 ± 1.2%) (Fig. 1).
10 ml of quantum red labelled anti-human CD4 or anti-human
CD8mAb for 30min at room temperature in dark. Two
millilitres of diluted FACS lysing solution (Becton-Dickinson, Ratio of IL -4, IL -10, IL -13 and IFN-c producing
Mountainview, CA, USA) was added to each tube for 10min CD4 + cells in PBMCin order to lyse the erythrocytes and to  x the plasma
membrane of leukocytes. Samples were centrifuged at 500 ´ g We examined the frequency of IL-4, IL-10, IL-13 and
for 5min and supernatants were removed. Diluted FACS IFN-c producing CD4+ T cells by  ow cytometry. Thepermeabilizing solution (0.5ml, Becton-Dickinson) was added
ratio of IL-10 producing CD4 + T cells in the patientsto each sample and these were incubated for 10min. After a
with CIU was signi cantly higher than that of con-washing step, the permeabilized cells were stained with FITC-
labelled anti-human IFN-c and phycoerythrin (PE)-labelled trol subjects (6.1 ± 5.4% versus 2.1 ± 1.19%; p <0.01)
anti-human IL-4 (both from Becton-Dickinson) or with
PE-labelled anti-human IL-10 (Caltag) or PE-labelled anti-
human IL-13 (Becton-Dickinson) antibodies for 30min at Table I. Serum immunoglobuli n levels (mean ±SD) in controls
room temperature in dark. The samples were washed again and patients with chronic idiopathic urticaria (n= 22 for both)
and  xed in 500 ml of 1% paraformaldehyde (Sigma). Cells
were analysed by a Coulter EPICS XL-4  ow cytometer. IgG IgA IgM IgE
Analyses gates were set on lymphocytes in accordance with
forward and side-scatter and their CD4 or CD8 positivity. Controls (g/l ) 11.2 ± 2.3 1.8 ± 0.7 0.9 ± 0.3 96.8 ± 21
Results were expressed as the percentage of cytokine-producing Patients (g/l ) 10.6 ± 2.4 2.0 ± 0.8 1.3 ± 0.6 146 ± 111
cells in each CD4+ or CD8+ T-cell population.
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test; 8 patients were negative. We made comparisons
between the data of the autologous serum skin test
positive and negative patient groups and observed no
signi cant diVerence between the two groups with regard
to the immunoglobulin levels, the subpopulations of
peripheral lymphocytes, the frequency of activated
T cells and the expression of intracellular cytokines (data
not shown).
DISCUSSION
The aetiology of chronic urticaria is still obscure. In the
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vast majority of subjects the causative allergen cannotFig. 1. Detection of activated T cells in patients with chronic idio-
be identi ed. The current concept is that CIU is auto-pathic urticaria (CIU). In order to quantify the rate of activated
immune in origin, at least in a subpopulation of patientsT cells in patients with CIU, whole blood T lymphocytes of controls
( , n= 22) and patients with CIU ( , n= 22) were labelled by a (14). In the present study, we investigated the character-
PE-conjugated anti-HLADR or anti-CD69mAb in combination with istic cytokine production of T cells in the PBMC of
a FITC-labelled anti-CD3mAb. The samples were measured by a patients suVering from CIU.Coulter EPICS XL-4  ow cytometer and lymphocytes were identi ed
First we measured the serum immunoglobulin levels.based on their scatter properties. The rate of CD3 + /HLADR + and
In the case of the IgG, IgA and IgM levels we did notCD3 + /CD69 + double positive cells expressed on the y-axis as the
percentage of positive cells among all lymphocytes.  nd any diVerence, while the median serum IgE level in
patients was higher than in the control population, but
(Fig. 2B). In contrast, the frequency of IFN-c producing the diVerence was not statistically signi cant. Sabroe
helper T cells from patients with CIU was signi cantly et al. (15) detected normal IgE levels in the sera of
lower than that of control subjects (17.0 ± 5.7% versus patients with CIU. They found lower serum IgE levels
22.06 ± 6.25%; p < 0.002) (Fig. 2A). The proportion of in those patients who had circulating anti-FceRIa or
IL-4 producing CD4 + T cells from patients with CIU anti-IgE antibodies than in patients without autoanti-
was also signi cantly lower than that of healthy control bodies. Allergen speci c IgE was not found in our
groups (0.5 ± 0.86% versus 1.12 ± 0.71%; p< 0.03) patient population.
(Fig. 2C ). The ratio of IL-13 producing CD4 + lympho- Barlow et al. (16) investigated T-cell subsets in biopsy
cytes was higher in patients than in the control group, specimens of patients with CIU and showed a prepon-
but the diVerence was not remarkable (0.21 ± 0.31% derance of CD4 + cells over CD8 + cells, while Malet
versus 0.14 ± 0.09%) (Fig. 2D). et al. (17) detected a signi cantly decreased CD8 +
T-cell count in the peripheral blood of chronic urticaria
Ratio of IL -4, IL -10, IL -13 and IFN-c producing patients. In our patient population, there was no signi-
CD8 + cells in PBMC  cant diVerence in the proportion of the CD3 + ,
CD4 + , CD8 + and CD19 + T and B lymphocytes asCytokine production of the CD8 + T cells was also
compared to the control group. While the number ofmeasured by  ow cytometry. The ratio of IL-10 produ-
CD3 + T lymphocytes was not elevated, the ratio ofcing CD8 + T cells in patients with CIU was signi cantly
activated, HLA-DR expressing CD3 + T lymphocyteshigher than in the case of healthy control subjects
was signi cantly higher.(8.63 ± 7.21% versus 1.98 ± 1.47%; p <0.001) (Fig. 2B).
With regard to the cytokine measurements, we couldThe ratio of IFN-c producing CD8 + T cells in patients
detect an elevated IL-10 production both in CD4 + andwith CIU was signi cantly lower than in healthy control
CD8 + T cells. The immune-regulatory cytokine IL-10subjects (27.6 ± 12.2% versus 43.4 ± 8.45%; p =0.0003 )
is produced by both Th1 and Th2 lymphocytes and(Fig. 2A). The frequency of IL-4 producing CD8 +
inhibits their antigen-speci c proliferation and cytokineT cells was higher in patients compared with the control
production (18). IL-10 has the ability to down-regulategroup (1.22 ± 4.04% versus 0.59 ± 0.72%) (Fig. 2C),
several major functions of Th1 cells and macrophagesand the ratio of IL-13 producing CD8 + T cells from
and can control also the Th2-mediated in ammatorypatients with CIU was also higher than that of healthy
processes (19). IL-10 also acts by down-regulating IL-12controls (Fig. 2D), but neither diVerence was statistically
production by antigen presenting cells, thereby pro-signi cant.
moting the diVerentiation of naive Th0 cells toward
a Th2 pro le, although the Th2-type response is
Comparison of the autologous serum skin test positive down-regulated in some situations as well (20, 21). Our
and negative patient groups results indicate that in consequence of the increased
IL-10 production the function of both Th1 and Tc1In the present study, 14 of the 22 patients gave an
immediate weal response in the autologous serum skin lymphocytes is impaired, which results in a decreased
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Fig. 2. Intracellular cytokine expression of stimulated T helper and T cytotoxic cells of patients with chronic idiopathic urticaria (CIU ) and
healthy controls. Whole blood T lymphocytes of healthy controls ( ) and patients with CIU ( ) were stimulated by phorbol myristate acetate
(PMA) and ionomycin in the presence of berefeldin A for 4 h at 37°C. The CD4 and CD8 surface molecules were marked by quantum red-
labelled mAbs, then the cells were  xed and permeabilized and the intracellular cytokines IFN-c (A), IL-4 (C), IL-10 (B) and IL-13 (D) were
stained by speci c FITC-labelled or PE-labelled mAb. The samples were measured with a Coulter EPICS XL  ow cytometer and the rate of
cytokine-containing cells among the CD4-positive and CD8-positive T cells was determined. The bars and error bars present the mean ± SD of
the result from controls and patients. The diVerences between the healthy controls and the patient with CIU were calculated by the Student’s t-test.
intracellular IFN-c content. The signi cant decrease in also has immunostimulatory properties, especially on B
cells. This eVect could contribute to the autoantibodythe intracellular IL-4 level of the CD4 + T lymphocytes
can be the result of the inhibitory eVect of IL-10 on production which is observed in patients with CIU. It
has recently become clear that between 27% and 50%Th2 cells. On the other hand, IL-10 may not completely
inhibit the cytokine production of Th2 and Tc2 lympho- of patients with CIU have functional autoantibodies
directed against the a-chain of the high aYnity IgEcytes because the decreased IFN-c content could have
an opposing in uence. Since IFN-c has the ability to receptor (FceRIa) (22). These antibodies are identi ed
by autologous serum skin testing and con rmed byinhibit Th2 cytokine production, an impaired IFN-c
production could be the reason for the increased histamine release studies or immunoblotting. In the
present study, 14 of the 22 patients gave an immediateintracellular IL-4 level in CD8 + cells. According to the
literature, the inhibitory activity of IL-10 is not promin- weal response in the autologous serum skin test, whereas
8 patients were negative. However, we did not observeent on IL-13 production. This may explain the increased
IL-13 production which we observed in both CD4 + any signi cant diVerence between the two groups.
The last decade has been an exciting time for theand CD8 + T lymphocytes, although these diVerences
were not signi cant. proponents of the Th1 and Th2 paradigm. Nevertheless,
the Th1/Th2 polarization cannot always be demon-Besides the inhibitory eVects of IL-10, this cytokine
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9. LeznoV A, Josse RG, Denburg J, Dolovich J. Associationstrated. In systemic autoimmune diseases such as in
of chronic urticaria and angioedema with thyroid autoim-systemic lupus erythematosus and Sjo¨gren’s syndrome,
munity. Arch Dermatol 1983; 119: 636–640.
both the Th1 and Th2 responses may be pathogenic 10. Mosmann TR, Sad S. The expanding universe of T-cell
(13). It is usually accepted that thyroid autoimmunity subsets: Th1, Th2 and more. Immunol Today 1996; 17:
138–146.is mediated by Th1 cells (12), but recent results show a
11. Seder RA, Boulay JL, Finkelman F, Barbier S, Ben-major diVerence in the balance of Th1 and Th2 cytokines
Sasson SL, Le-Gros GG, et al. CD8 + T cells can besecreted by cultures of thyroid and peripheral blood
primed in vitro to produce IL-4. J Immunol 1992;
lymphocytes (23). Our data do not show a characteristic 148: 1652–1656.
Th1 type or Th2 type cytokine pattern in the PBMC of 12. Del Prete G. The concept of type-1 and type-2 helper
T cells and their cytokines in humans. Int Rev Immunolpatients suVering from CIU. From these results we
1998; 16: 427–455.cannot conclude to the cytokine pattern of lesional skin
13. Singh VK, Mehrotra S, Agarwal SS. The paradigm of thein CIU patients; further investigation is needed to answer
Th1 and Th2 cytokines: its relevance to autoimmunity
this question (24, 25, 26). and allergy. Immunol Res 1999; 20: 147–161.
Taken together, our study has produced the  rst 14. Tong LJ, Balakrishnan G, Kochan JP, Kinet JP, Kaplan
AP. Assessment of autoimmunity in patients with chronicresults on the cytokine production of PBMC in chronic
urticaria. J Allergy Clin Immunol 1997; 99: 461–465.urticaria. We could observe neither a dominant Th1 nor
15. Sabroe RA, Seed PT, Stat C, Francis DM, Barr RM,a dominant Th2 type cytokine pattern and our results
Kobza-Black A, et al. Chronic idiopathic urticaria: com-
were similar with regard to the cytotoxic T cells. We parison of the clinical features of patients with and without
measured a signi cant elevation in the intracellular IL-10 anti-FceRI or anti-IgE autoantibodies. J Am Acad
Dermatol 1999; 40: 443–450.level and this may be the cause of the down-regulated
16. Barlow RJ, Ross EL, MacDonald DM, Kobza-Black A,Th1 and Tc1 and partly Th2 lymphocyte functions.
Greaves MW. Mast cells and T lymphocytes in chronic
urticaria. Clin Exp Allergy 1995; 25: 317–322.
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